Lilly Eyes Aesthetic Medicine as GLP-1 Weight Loss Reshapes Faces
Eli Lilly is exploring aesthetic medicine as GLP-1 patients face facial volume loss and laxity — but no products, trials, or timelines are confirmed yet.
Topic
Topic
Eli Lilly is exploring aesthetic medicine as GLP-1 patients face facial volume loss and laxity — but no products, trials, or timelines are confirmed yet.
Merz Aesthetics is stepping up expansion to capture surging demand for aesthetic treatments, NST Online reports, without yet nami…
Eli Lilly is exploring aesthetic medicine as GLP-1-driven weight loss creates visible facial and body changes, the Indianapolis B…
Dermatology Advisor brands aesthetic medicine "the Wild West": demand for cosmetic procedures is booming while injector training…
India's cosmetic dermatology surge is psychological, not pathological, ThePrint reports — clinics are treating feelings about ski…
A Cureus paper proposes the Beauty Health Index, a composite score designed to quantify facial aesthetic health and replace subje…
Rochester aesthetic medicine practices report rising demand and a younger patient mix, the Rochester Business Journal says. Injec…
The FDA has requested additional manufacturing information on TrenibotE, the quick-acting botulinum toxin candidate, according to…
A Verywell Health feature asks whether beauty's drift into medicine harms patients, a question dermatologists increasingly face a…
DermDox Group has acquired Modern Aesthetics Plastic Surgery, adding surgical and aesthetic capabilities to its four-state dermat…